Related Experiment Video

Updated: Aug 17, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

Neuropsychiatric symptoms during treatment with interleukin-2 and interferon-alpha

M H Fenner, E L Hänninen, H H Kirchner

    Lancet (London, England)
    |February 6, 1993
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
    09:38

    Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

    Published on: September 12, 2016

    Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles
    09:57

    Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

    Published on: June 28, 2021

    Related Experiment Videos

    Last Updated: Aug 17, 2026

    High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
    10:00

    High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

    Published on: March 24, 2015

    Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
    09:38

    Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

    Published on: September 12, 2016

    Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles
    09:57

    Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

    Published on: June 28, 2021

    Related Concept Videos

    Myasthenia Gravis: Overview and Treatment01:20

    Myasthenia Gravis: Overview and Treatment

    Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
    These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
    T Cell Types and Functions01:24

    T Cell Types and Functions

    When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
    Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

    Articles linked to this work by shared authors, journal, and citation graph.

    Dynamics in treatment response and disease progression of metastatic colorectal cancer (mCRC) patients with focus on BRAF status and primary tumor location: analysis of untreated RAS-wild-type mCRC patients receiving FOLFOXIRI either with or without panitumumab in the VOLFI trial (AIO KRK0109).

    Journal of cancer research and clinical oncology·2020

    A nine-gene signature predicting clinical outcome in cutaneous melanoma.

    Journal of cancer research and clinical oncology·2012

    Antitumor-activity and toxicity of continuous-infusion versus bolus administration of bleomycin in 2 heterotransplanted human testicular cancer cell-lines.

    Oncology reports·2011

    Late relapse of testicular cancer presenting as differentiated teratoma - report of a case and discussion of the clinical implications.

    Oncology reports·2011

    Metastatic leydig-cell tumors of the testis - report of 4 cases and review of the literature.

    International journal of oncology·2011

    Treatment of adult osteosarcoma - single-center results in 47 patients.

    International journal of oncology·2011

    Targeted left ventricular lead placement in biventricular pacing for heart failure: a national, multicentre, double-blind, randomised controlled trial in Denmark.

    Lancet (London, England)·2026

    Catheter ablation for symptomatic atrial fibrillation (PVI-SHAM-AF): a randomised, double-blind, sham-controlled, multicentre trial.

    Lancet (London, England)·2026

    Cardiovascular disease in pregnancy: physiology, global burden, risk stratification, and opportunities in care.

    Lancet (London, England)·2026

    Aetiology, management, and outcomes of acute heart failure in 17 African countries (THESUS-HF II): a prospective, multicentre, observational cohort study.

    Lancet (London, England)·2026

    Adverse pregnancy outcomes and long-term cardiovascular disease risk.

    Lancet (London, England)·2026

    Discontinuation of β-blockers in stable patients with previous myocardial infarction, preserved left ventricular ejection fraction, and no heart failure: a pooled analysis of individual patient data.

    Lancet (London, England)·2026

    Genital Herpes in an HIV-Positive Patient Mimicking Donovanosis: A Case Report.

    Cureus·2026

    Olfactory Hallucinations as the Initial Symptom of Anti-Leucine-Rich Glioma-Inactivated 1 Antibody Encephalitis: A Case Report and Review of the Literature.

    Cureus·2026

    Oral lichen planus possibly associated with Hashimoto's thyroiditis: A case-control study in a northwest Chinese population.

    Journal of dental sciences·2026

    Gastric parietal cell and thyroid autoantibodies in patients with oral lichen planus.

    Journal of dental sciences·2026

    Apolipoprotein L1 risk genotypes and odds of lupus nephritis-associated kidney failure in systemic lupus erythematosus: a systematic review and meta-analysis.

    Frontiers in medicine·2026

    Decoding Treg diversity and dysfunction to advance Treg-based therapies in autoimmune and inflammatory diseases.

    Frontiers in immunology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us